In English | En español
Questions About Cancer? 1-800-4-CANCER
American Reinvestment and Recovery Act

Page Options

  • Print This Page
  • Email This Document

Additional Recovery Act Resources from NIH

NIH and the Recovery Act


Thank you for visiting our News section where you will find links to recent articles within NCI and from around the country that showcase the impact of the Recovery Act.


News from NCI

Strengthening Community-Based Cancer Care through Recovery Act FundingMay 16, 2011
The NCI Community Cancer Centers Program (NCCCP) has enhanced the level of science-based cancer care and research at community hospitals since 2007. With recent Recovery Act funding, the NCCCP network has expanded to 30 cancer centers in 22 states, bringing the latest scientific advances to more patients, and the potential for creating nearly 300 new jobs in the process.
Read more

Recovery Act Investment in Small Businesses Helping to Drive Innovation in Cancer CareMarch 21, 2011
Government-funded programs such as the National Cancer Institute's Small Business Innovation Research and Small Business Technology Transfer (NCI SBIR & STTR) programs play an important role in helping small businesses bring innovative ideas for improving cancer care to market. Without financial assistance, new technologies or therapies that can benefit cancer patients may never become a reality. SBIR-funded grantees are eligible for supplementary American Recovery and Reinvestment Act (Recovery Act) funding. With the help of this combined assistance, small businesses are able to retain and hire new staff, and continue advancing potentially life-saving products in ways that would not be possible without the funding support.
Read more

Searching the Genome to Understand Cancer Disparities among Minority PopulationsJune 28, 2010
Recovery Act funding is enabling collaboration among researchers from different institutions to conduct sizeable genome-wide association studies (GWAS) to better understand the causes, incidences and mortality of leading cancers that disproportionately affect some minority populations.
Read more

Recovery Act Funding Helping to Inform Personalized MedicineMay 5, 2010
A pilot study made possible by Recovery Act funds is studying the feasibility and scalability of emerging technologies to map all of the 250,000 to one million proteins in the human body. 
Read more

ARRA Funds Support Comparative Effectiveness Research in Cancer - March 4, 2010
Recovery Act funding is stimulating scientific research to help evaluate and compare different options in cancer screening, diagnosis and care. Comparative Effectiveness Research now underway is laying the groundwork to help improve patient outcomes while improving overall healthcare value.
Read more

See more>>


Headlines from Around the Country

Probing poor prognoses for breast cancer - October 2010
A new research project at the University of Chicago is examining what genetic factors may predict outcomes among women with early onset breast cancer. This work is being made possible by a two-year $1million American Recovery and Reinvestment Act grant funded by the National Cancer Institute.

Vice President Biden releases new report on 100 Recovery Act Projects Changing America, cites TCGA - September 2010
From the Office of the Vice President at
"100 Recovery Act Projects that are Changing America," a new report issued by Vice President Joe Biden, highlights some of the most innovative and effective projects funded by the Recovery Act. Among the projects featured, NCI-sponsored "The Cancer Genome Atlas Project" was singled out for its potential to "fundamentally change cancer research and, ultimately, cancer treatment."

A World Apart: Cultural barriers hamper Portland's Hmong community in health-care system - July 2010
From the Oregon State University College of Health & Human Sciences' Synergies. A study, funded by the National Cancer Institute through the American Recovery and Reinvestment Act, is exploring factors that may explain the high rates of cervical cancer mortality in Hmong women, as well as their low rates of preventive mammography and Pap tests.

See more>>